CAM
EXAS

ClariVest Asset Management’s Exact Sciences EXAS Stock Holding History

ClariVest Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.07M Hold
25,364
– – 0.11% 250
2024
Q2 		$1.07M Buy
25,364
+51
+0.2% +$2.81K 0.11% 250
2024
Q1 		$1.75M Buy
25,313
+6,192
+32% +$392K 0.18% 166
2023
Q4 		$1.41M Buy
19,121
+7,337
+62% +$481K 0.08% 185
2023
Q3 		$804K Buy
11,784
+23
+0.2% +$1.95K 0.04% 278
2023
Q2 		$1.1M Buy
+11,761
New +$917K 0.06% 233
2021
Q2 		– Sell
-15,870
Closed -$2.09M – 776
2021
Q1 		$2.09M Sell
15,870
-200
-1% -$27.4K 0.07% 202
2020
Q4 		$2.13M Sell
16,070
-19,800
-55% -$2.39M 0.07% 210
2020
Q3 		$3.66M Sell
35,870
-830
-2% -$71.7K 0.12% 142
2020
Q2 		$3.19M Buy
36,700
+2,800
+8% +$224K 0.09% 171
2020
Q1 		$1.97M Buy
33,900
+2,300
+7% +$187K 0.06% 200
2019
Q4 		$2.92M Sell
31,600
-1,400
-4% -$123K 0.07% 201
2019
Q3 		$2.98M Sell
33,000
-200
-0.6% -$22.8K 0.07% 210
2019
Q2 		$3.92M Sell
33,200
-100
-0.3% -$10.1K 0.09% 183
2019
Q1 		$2.88M Buy
33,300
+20,100
+152% +$1.71M 0.06% 260
2018
Q4 		$833K Hold
13,200
– – 0.02% 414
2018
Q3 		$1.04M Hold
13,200
– – 0.02% 420
2018
Q2 		$789K Sell
13,200
-41,762
-76% -$2.25M 0.01% 472
2018
Q1 		$2.22M Buy
54,962
+200
+0.4% +$9.76K 0.04% 327
2017
Q4 		$2.88M Buy
54,762
+12,989
+31% +$694K 0.05% 281
2017
Q3 		$1.97M Hold
41,773
– – 0.05% 287
2017
Q2 		$1.48M Buy
+41,773
New +$1.29M 0.04% 306
2017
Q1 		– Sell
-3,397
Closed -$45K – 700
2016
Q4 		$45K Buy
+3,397
New +$54.8K ﹤0.01% 575

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ClariVest Asset Management's EXAS Position: Q3 2024 in Review

ClariVest Asset Management held its Exact Sciences (EXAS) position steady in Q3 2024 at 25,364 shares worth $1.07M. The position accounts for 0.11% of the portfolio, ranked #250.

ClariVest Asset Management first reported a position in EXAS in Q4 2016 and has held it in 23 quarters since. The position peaked at $3.92M in Q2 2019. 599 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • ClariVest Asset Management held 25,364 shares of Exact Sciences worth $1.07M as of Q3 2024.
  • ClariVest Asset Management left its Exact Sciences share count unchanged in Q3 2024.
  • Exact Sciences made up 0.11% of ClariVest Asset Management's portfolio in Q3 2024, its #250 holding.
  • ClariVest Asset Management first reported a position in Exact Sciences in Q4 2016 and has held it in 23 quarters since.
  • ClariVest Asset Management's Exact Sciences position peaked at $3.92M in Q2 2019.
  • 599 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.